Virtual Event
Advocacy partner: EB Research Partnership
About EB Research Partnership
The mission of EB Research Partnership is to advance life-saving treatments, and ultimately, find a cure for epidermolysis bullosa (EB) by the end of this decade. Secondarily, EBRP’s innovative model is leading the way for all rare diseases. While EB is a rare disease, there are 7,000 rare diseases that affect 1 in 10 people in the world, 95% which have no treatments, that can benefit from the research we fund and our innovative Venture Philanthropy model – both of which are scalable to all rare diseases. Click here to watch The Story of the EB Research Partnership!
Contact: Allison McGettigan – Director of Programs
Phone: 646-844-0902
Email: [email protected]
Upcoming events
About Advocacy Partners
The information above is provided by our partner. Learn more about our advocacy partners here.
Recent Posts
- Children’s Hospital Colorado set to provide Zevaskyn for RDEB
- Most patients report beneficial effect from Filsuvez on EB wounds
- Filsuvez cuts time, money spent on EB dressing changes: Trial data
- FDA update allows at-home gene therapy for all DEB patients
- Skin wound type may be key to designing clinical trials for RDEB